Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · IEX Real-Time Price · USD

0.428

+0.012 (2.89%)

At close: Jul 26, 2024, 3:54 PM

0.415

-0.013 (-3.01%)

After-hours: Jul 26, 2024, 7:04 PM EDT

Ensysce Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-11.54	-10.61	-24.17	-29.08	0.06	-10.1
Depreciation & Amortization	-	-	-	0	0	0
Other Amortization	1.5	0.33	0.95	1.92	-	-
Loss (Gain) From Sale of Assets	-	-	-0	-	-	-
Stock-Based Compensation	0.8	0.88	1.07	0.12	0.18	6.04
Other Operating Activities	-0.04	-0.43	-1.21	20.1	-1.67	1.53
Change in Accounts Receivable	0.19	0.18	0.16	-0.44	0.17	-0.17
Change in Accounts Payable	-1.18	-1.23	2.64	-1.42	1.18	0.37
Change in Other Net Operating Assets	-0.3	0.11	2.67	0.56	-1.17	1.4
Operating Cash Flow	-10.58	-10.78	-17.89	-8.24	-1.25	-0.94
Sale of Property, Plant & Equipment	-	-	0	-	-	-
Investing Cash Flow	-	-	0	-	-	-
Short-Term Debt Issued	-	-	-	-	-	0.1
Long-Term Debt Issued	-	1.61	7.53	14.38	1.1	0.4
Total Debt Issued	1.61	1.61	7.53	14.38	1.1	0.5
Long-Term Debt Repaid	-	-1.45	-2	-0.96	-	-
Total Debt Repaid	-1.47	-	-	-	-	-
Net Debt Issued (Repaid)	0.13	0.15	5.53	13.42	1.1	0.5
Issuance of Common Stock	8.44	9.05	3.78	6.89	-	-
Other Financing Activities	4	-0.45	-0.55	-	0	-
Financing Cash Flow	12.57	8.76	8.77	20.31	1.1	0.5
Net Cash Flow	1.99	-2.02	-9.12	12.07	-0.15	-0.44
Free Cash Flow	-10.58	-10.78	-17.89	-8.24	-1.25	-0.94
Free Cash Flow Margin	-605.83%	-483.29%	-708.87%	-233.41%	-31.73%	-53.02%
Free Cash Flow Per Share	-3.09	-4.76	-99.42	-98.10	-18.13	-0.94
Cash Income Tax Paid	0	0	0	0	0	0
Levered Free Cash Flow	-6.86	-7.42	-11.19	-14.66	-3.27	-
Unlevered Free Cash Flow	-7.36	-7.53	-11.36	-14.57	-2.65	-
Change in Net Working Capital	1.9	1.71	-2.71	2.28	1.82	-

Source: S&P Capital IQ. Standard template.